Dr. Manish Prasad Shrestha, MD

Dr. Shrestha practices at Digestive Disease Center - HOPD in Laguna Hills, California.

Dr. Shrestha's NPI, 1407135411, was assigned on August 8, 2011. Dr. Shrestha graduated from B.P. Koirala Institute of Health Sciences in 2007. Dr. Shrestha holds California license A177487.

Dr. Shrestha's primary practice is Digestive Disease Center - HOPD, at 24411 Health Center Dr, Laguna Hills, CA 92653.

Dr. Shrestha's primary practice is Digestive Disease Center - HOPD in Laguna Hills, California. Dr. Shrestha is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Shrestha to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrestha practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Shrestha's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Shrestha is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Shrestha's licenses on file in 4 states: California, New Mexico, Arizona and Illinois.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis, colonoscopy, gastroenteritis, gastrointestinal bleeding and upper GI endoscopy among the conditions Dr. Shrestha treats.

CMS data shows 405 Medicare services from Dr. Shrestha across 9 procedure codes in 2024, for 204 Medicare patients. Medicare paid $28,107 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Shrestha in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 80% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrestha's median patient age at 61, with 51% women.

In 2024, Dr. Shrestha wrote 203 Medicare Part D claims for 51 patients. 65% of them were for generic drugs. CMS names the drug for 132 of them, across 5 drugs with 11 or more claims each, at $702,345 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shrestha for performance year 2024, reported as part of a group. Dr. Shrestha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Shrestha, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Shrestha, published from 2015 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Clostridium Infections, Colectomy and Inpatients. Dr. Shrestha has published most often in Cureus. Dr. Shrestha's most frequent co-authors are Shefali Amin, DO, Sasha Taleban, MD and Anthony A. Donato, MD.

CMS Open Payments shows 42 general payments to Dr. Shrestha from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Cook Medical LLC paid the most, $656.

Dmand AI lists 5 awards for Dr. Shrestha, most recently National Visiting Fellow IBD Rotation Program at Cedars-Sinai Medical Center in Los Angeles, California in 2022.

Dr. Shrestha graduated from B.P. Koirala Institute of Health Sciences in 2007.

Dr. Shrestha is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.